Flixene Vascular Grafts
Flixene is a unique 3 layer ePTFE graft designed for use in both vascular bypass and AV Access graft applications. The 3 layer construction provides Flixene significantly improved strength and durability over previous Getinge (formerly Maquet) single and double layer ePTFE grafts. To address a broad number of patient needs, Flixene grafts are offered in a variety of configurations including:
Getinge offers an extensive line of straight grafts. Straight grafts are often used for those applications where a bypass is needed and vessel diameter remains a constant from the proximal to the distal anastomosis.
A wide selection of tapered grafts is also offered for those clinical applications where flow dynamics need to be altered or when performing a bypass between two different diameter vessels. 
Each of the above graft configurations is offered in both graduated wall and standard wall thickness.
Graduated Wall (GW)
To offer physicians improved suturability and handling, the Flixene GW grafts offer a reduced wall thickness at the proximal and distal 8cm segments of the graft. Getinge’s engineers were able to achieve this without reducing the strength and durability of the Flixene GW in comparison to that of our standard wall grafts which remain an active part of our portfolio. 
Standard Wall (SW)
Getinge also offers a full line of standard wall thickness grafts.
Flixene AV access graft brochure
Learn more about the Flixene AV access graft. Flixene includes a slider GDS system with plastic sheath for easy tunneling, reduced soft tissue trauma and targeted placement. Flixene is shown to be a viable option for early cannulation within 3 days, reducing the need and risks associated with CVCs for patients
Data on file
Schild AF, Schuman ES, Noicely K, et al. Early cannulation prosthetic graft (Flixene) for arteriovenous access. J Vasc Access. 2011 Jul-Sep;12(3):248-52.
Schild AF, Baltodano NM, Alfieri K, Livingstone J, Raines JK. New Graft for Low Friction Tunneling in Vascular Access Surgery. J Vasc Access. 2004 Jan-Mar;5(1):19-24.